NM_004924.6:c.1998G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_004924.6(ACTN4):c.1998G>A(p.Gln666Gln) variant causes a synonymous change. The variant allele was found at a frequency of 0.00944 in 1,613,652 control chromosomes in the GnomAD database, including 118 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0066 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0097 ( 110 hom. )
Consequence
ACTN4
NM_004924.6 synonymous
NM_004924.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 6.91
Publications
1 publications found
Genes affected
ACTN4 (HGNC:166): (actinin alpha 4) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes. Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008]
ACTN4 Gene-Disease associations (from GenCC):
- focal segmental glomerulosclerosis 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 19-38724553-G-A is Benign according to our data. Variant chr19-38724553-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00658 (1002/152378) while in subpopulation NFE AF = 0.0111 (756/68044). AF 95% confidence interval is 0.0105. There are 8 homozygotes in GnomAd4. There are 467 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1002 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACTN4 | NM_004924.6 | c.1998G>A | p.Gln666Gln | synonymous_variant | Exon 16 of 21 | ENST00000252699.7 | NP_004915.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACTN4 | ENST00000252699.7 | c.1998G>A | p.Gln666Gln | synonymous_variant | Exon 16 of 21 | 1 | NM_004924.6 | ENSP00000252699.2 |
Frequencies
GnomAD3 genomes AF: 0.00659 AC: 1004AN: 152260Hom.: 8 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1004
AN:
152260
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00842 AC: 2106AN: 250048 AF XY: 0.00872 show subpopulations
GnomAD2 exomes
AF:
AC:
2106
AN:
250048
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00974 AC: 14234AN: 1461274Hom.: 110 Cov.: 36 AF XY: 0.00971 AC XY: 7057AN XY: 726952 show subpopulations
GnomAD4 exome
AF:
AC:
14234
AN:
1461274
Hom.:
Cov.:
36
AF XY:
AC XY:
7057
AN XY:
726952
show subpopulations
African (AFR)
AF:
AC:
58
AN:
33470
American (AMR)
AF:
AC:
59
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
50
AN:
26128
East Asian (EAS)
AF:
AC:
0
AN:
39698
South Asian (SAS)
AF:
AC:
758
AN:
86250
European-Finnish (FIN)
AF:
AC:
448
AN:
52922
Middle Eastern (MID)
AF:
AC:
8
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
12439
AN:
1111940
Other (OTH)
AF:
AC:
414
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1053
2106
3158
4211
5264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00658 AC: 1002AN: 152378Hom.: 8 Cov.: 32 AF XY: 0.00627 AC XY: 467AN XY: 74514 show subpopulations
GnomAD4 genome
AF:
AC:
1002
AN:
152378
Hom.:
Cov.:
32
AF XY:
AC XY:
467
AN XY:
74514
show subpopulations
African (AFR)
AF:
AC:
81
AN:
41592
American (AMR)
AF:
AC:
35
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
8
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
42
AN:
4828
European-Finnish (FIN)
AF:
AC:
71
AN:
10626
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
756
AN:
68044
Other (OTH)
AF:
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Nov 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
ACTN4: BP4, BP7, BS1, BS2 -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Focal segmental glomerulosclerosis Benign:1
Dec 15, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Focal segmental glomerulosclerosis 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.